Evidence map›Paper›PMID 40919781›Full record

ArticleMicrobiology spectrum2025

H1N1pdm09 returns: a comparative study in Anhui, China.

Si-Tian Yang, Min-Hao Hu, Wei-Xi Fang, Hui-Min Diao, Harry Asena Musonye, Ji-Xiang Huang, Yi-Dan Xia, Jun-Ling Yu, Lei Gong, Sai Hou and 7 more

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Si-Tian Yang *Anhui Provincial Center for Disease Control and Prevention, Hefei, China.
Min-Hao Hu *School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Wei-Xi Fang *Anhui Provincial Center for Disease Control and Prevention, Hefei, China.
Hui-Min Diao *Anhui Academy of Medical Sciences, Hefei, China.
Harry Asena Musonye *School of Public Health, Anhui Medical University, Hefei, Anhui, China.
Ji-Xiang HuangAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
Yi-Dan XiaSchool of Public Health, Anhui Medical University, Hefei, Anhui, China.
Jun-Ling YuAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
Lei GongAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
Sai HouAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
De-Xi LiSchool of Public Health, Anhui Medical University, Hefei, Anhui, China.
Wan-Rong LuoAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
Xue ZhouAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
Xian-Wei LuoAnhui Provincial Center for Disease Control and Prevention, Hefei, China.
Jia-Bing WuAnhui Provincial Center for Disease Control and Prevention, Hefei, China.ORCID 0000-0002-2104-1755
Hai-Feng PanInflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, Anhui, China.ORCID 0000-0001-8218-5747
Jun HeAnhui Provincial Center for Disease Control and Prevention, Hefei, China.ORCID 0000-0002-0463-7063

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The 2022/2023 season witnessed a rapid resurgence of H1N1pdm09 in Anhui Province, China, surpassing previous years, prompting an examination of hemagglutinin (HA) gene mutations and cross-immunity in this study. Anhui Province's surveillance data established the detection threshold for H1N1pdm09 using the Moving Epidemic Method. Joinpoint regression compared weekly percent change (WPC) rates. A total of 103 strains of H1N1pdm09 were sequenced and analyzed, and cross-reactivity was assessed using

Indexed as

Influenza A Virus, H1N1 SubtypeInfluenza, HumanChinaCross ReactionsDisease OutbreaksHemagglutinin Glycoproteins, Influenza VirusHumansMutationSeasonsHemagglutinin Glycoproteins, Influenza Viruscontrol strategycross-immunity protectionepidemiology of influenzaH1N1pdm09 outbreakHA gene mutations

Identifiers

PMID40919781
PMCPMC12502789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.